TLV Equity Snapshot

BLRX Weekly Equity Report

BioLineRx Ltd.

Interactive chart JSON snapshot
Latest Close 1.60 ILA 12 Jun 2026
1W Return 0.0% latest completed week
4W Return 14.3% short-term follow-through
12W Return 14.3% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
Company Brief

What the company does

BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx …

Snapshot

What the weekly tape is saying

BLRX closed the latest completed week at 1.60 ILA. The 4-week return is 14.3% and the 12-week return is 14.3%. Trend Signal is inactive, Market Dynamics is 1.59. Setup signature: Risk-first tape with a 31/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 5.7%
Volume 0.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 96 Blend of 4-week and 12-week follow-through.
Dynamics 80 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 13 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
1.51 ILA
Vs Trend Line
5.7%
Fair Value
14.60 ILA
Vs Fair Value
-89.0%
52W High
3.10 ILA
52W Low
1.10 ILA
Drawdown
-48.4%
Range Position
25.0%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W 14.3%
12W 14.3%
26W -5.9%
52W -46.7%

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
IL Healthcare
Sector Rank
21 of 51
Sector Percentile
60.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.59
4W MD Change
13.2%
Relative Strength
-29.73
4W RS Change
32.4%
Expectation
Negative
Probability
30.34%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
8.9M
13W Average
29.3M
52W Average
22.1M
Vs 13W
0.3x
Vs 52W
0.4x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
9.7%
52W Volatility
6.4%
Upside Weeks
9
Downside Weeks
19
Downside Breadth
36.5%
Avg Gain / Loss
9.3% / -7.2%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
TLV
Country
IL
Sector
Healthcare
Industry
Biotechnology
Currency
ILA
Market Cap
41.8M

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
  • Recent volatility is running well above the one-year baseline.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 1.60 ILA 0.0% 1.51 ILA 14.60 ILA 1.59 -29.73 8.9M Off
5 Jun 2026 1.60 ILA 0.0% 1.52 ILA 14.85 ILA 1.59 -30.38 15.4M Off
29 May 2026 1.60 ILA 23.1% 1.53 ILA 15.08 ILA 1.69 -34.75 44.8M Off
22 May 2026 1.30 ILA -7.1% 1.54 ILA 15.32 ILA 1.64 -47.07 65.9M Off
15 May 2026 1.40 ILA -12.5% 1.57 ILA 15.55 ILA 1.40 -43.95 33.1M Off
8 May 2026 1.60 ILA 14.3% 1.59 ILA 15.76 ILA 1.11 -38.62 52.0M Off
1 May 2026 1.40 ILA 7.7% 1.62 ILA 15.99 ILA 0.83 -45.87 70.0M Off
24 Apr 2026 1.30 ILA 0.0% 1.65 ILA 16.16 ILA 0.35 -49.68 4.0M Off
17 Apr 2026 1.30 ILA 0.0% 1.67 ILA 16.31 ILA 0.40 -50.85 8.8M Off
10 Apr 2026 1.30 ILA 8.3% 1.70 ILA 16.46 ILA 0.42 -51.85 15.7M Off
3 Apr 2026 1.20 ILA -7.7% 1.73 ILA 16.61 ILA 0.38 -53.47 4.8M Off
27 Mar 2026 1.30 ILA -7.1% 1.76 ILA 16.75 ILA 0.45 -49.21 46.7M Off
20 Mar 2026 1.40 ILA -6.7% 1.79 ILA 16.87 ILA 0.26 -48.73 11.0M Off
13 Mar 2026 1.50 ILA 0.0% 1.81 ILA 16.97 ILA 0.06 -44.15 12.9M Off